Telemonitoring of Chronic Wound Patients Using MyDerm, a Digital Solution: Feasibility Study
NCT ID: NCT06704087
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2025-02-06
2025-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Outcome measure 1 :
Evaluate patient satisfaction after 2 months of using the MyDerm solution.
Outcome measure 2 :
1. Evaluate caregiver satisfaction after 2 months of patient use of MyDerm solution.
2. Assess patient use (compliance, frequency) of MyDerm solution
3. Evaluate caregiver use of PIXACARE solution
4. Evaluate the impact of patients' socio-demographic characteristics (age, gender, level of education: primary/secondary/tertiary, rural/urban) on use of the MyDerm solution.
5. Evaluate the impact of patients' clinical characteristics on the use of the MyDerm solution.
Researchers will compare standard of care arm vs remote monitoring arm.
As part of remote monitoring, patients are invited to take photos of their wounds using their smartphone, and to answer a simple questionnaire to look for signs of complications. To assess satisfaction, the patient will complete a questionnaire after 2 months' use, using a 7-level Likert scale.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Improved Preparation Time to a Coverage in Patients With Acute Wounds by Use of VistaCare® Versus Dressings
NCT02963519
Study Evaluating the Effectiveness of Treatment With Vista Care®, in Arterial Ulcers of the Lower Extremities
NCT05133570
The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care
NCT02818322
DermaRep™ Device in the Treatment of Venous Leg Ulcers
NCT03699072
BioimPEDance of Diabetic Foot Ulcers
NCT02405767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical data will be collected by the investigating team during the primary consultation.
Patient satisfaction surveys will be sent in paper format to patients at the consultation scheduled at the end of the two-month follow-up period.
Caregiver" satisfaction surveys will be sent in paper format to caregivers at the end of the study.
The number of actions taken in response to an alert (by telephone, by message, organization of a physical consultation, organization of a teleconsultation, hospitalization) will be recorded in the post-alert action traceability form
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemonitoring
patients with chronic wounds of the lower limb benefiting from the digital solution for remote monitoring of healing.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Benefiting from the MyDerm digital wound-healing monitoring solution
* Patient aged 18 or over
* Informed patient who has not objected to the use of data
Exclusion Criteria
* Patient included in a clinical trial
* Patient with a life expectancy shorter than the duration of the study
* Patient with cognitive impairment
* Inability to install or use the medical device for technical reasons (lack of internet connection, lack of 4G coverage or more, lack of smartphone)
* Patient requiring home hospital care
* Patient requiring Follow-up and rehabilitation care
* Pregnant or breast-feeding women
* Patient with a previously infected wound
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pixacare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/001/Pixacare
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.